Nephros Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $20.7M+46.3% YoYTTM through 30 Jun 2026
Net Income $1.7M+2,245.9% YoYTTM through 30 Jun 2026
Free Cash Flow -$761KTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 57.0% |
| EBITDA Margin | 8.5% |
| Operating Margin | 18.7% |
| Net Margin | 8.4% |
Returns
7.3%ROE
5.7%ROA
23.9%ROIC
Balance Sheet Health
Debt / Equity0.00x
Current Ratio4.55x
Net Debt-$4Mnet cash position
Cash & Equivalents$4.7M
Quality Metrics
Altman Z-Score-3.00
Piotroski F-Score3 / 9
FCF Margin-3.7%
Rule of 402.7
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $18.8M
Diluted EPS$0.16TTMFY2025: $0.11
Dividend
No dividend
Capital Allocation
R&D Spend$1.4M
Capex Intensity0.3%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.